John A. Lewicki
2015
In 2015, John A. Lewicki earned a total compensation of $1.4M as Executive Vice President, Research and Development at OncoMed Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $170,625 |
|---|---|
| Option Awards | $884,058 |
| Salary | $390,000 |
| Total | $1,444,683 |
Lewicki received $884.1K in option awards, accounting for 61% of the total pay in 2015.
Lewicki also received $170.6K in non-equity incentive plan and $390K in salary.
Rankings
In 2015, John A. Lewicki's compensation ranked 6,183rd out of 13,638 executives tracked by ExecPay. In other words, Lewicki earned more than 54.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,183 out of 13,638 | 55th |
Division Manufacturing | 2,314 out of 5,187 | 55th |
Major group Chemicals And Allied Products | 834 out of 1,857 | 55th |
Industry group Drugs | 667 out of 1,531 | 56th |
Industry Pharmaceutical Preparations | 520 out of 1,179 | 56th |
Source: SEC filing on April 13, 2017.
Lewicki's colleagues
We found two more compensation records of executives who worked with John A. Lewicki at OncoMed Pharmaceuticals in 2015.